Percutaneous Retrieval of Left Atrial Appendage Closure Devices With an Endoscopic Grasping Tool

Percutaneous Left Atrial Appendage€Closure

Ma Percutaneous left atrial appendage closure technology for stroke prevention in patients with atrial fibrillation has significantly advanced in the past 2 decades. Several devices are under clinical investigation, and a few have already received Conformité Européene (CE)-mark approval and are available in many countries. The WATCHMAN device (Boston Scientific, Natick, Massachusetts) has the m...

Left Atrial Appendage Closure Devices

Atrial fibrillation (AF) increases the risk for thromboembolic stroke five-fold. The left atrial appendage (LAA) has been shown to be the main source of thrombus formation in the majority of strokes associated with AF. Oral anticoagulation with warfarin and novel anticoagulants remains the standard of care; however, it has several limitations, including bleeding and poor compliance. Occlusion o...

Percutaneous Closure of the Left Atrial Appendage.

This article reviews the published evidence on stroke prevention with percutaneous closure of the left atrial appendage and provides comparative insight into the various left atrial appendage closure devices currently in development.

Retrieval of a Disconnected Left Atrial Appendage Occluder with Endoscopic Grasping Forceps

Percutaneous Left Atrial Appendage Closure With the Watchman Device

Fro con Ca GT Lu Te kin of Ma OBJECTIVES The aim of this study was to evaluate long-term outcomes in patients with atrial fibrillation undergoing percutaneous left atrial appendage (LAA) closure with the Watchman device. BACKGROUND Atrial fibrillation is one of the most common arrhythmias and is associated with a high risk for cardioembolic ischemic events, most notably stroke. Percutaneous LAA...